SOURCE: Titan Medical Inc.

Titan Medical Inc.

September 06, 2016 08:51 ET

Titan Medical's Sport™ Surgical System to Be Featured in Presentation by Leading Urological Surgeon at the 13th Annual Meeting of the EAU Robotic Section in Milan, Italy

TORONTO, ON--(Marketwired - September 06, 2016) - Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"), today announced that Dr. Rafael Sanchez-Salas of the Institute Mutualiste Montsouris (Paris, France) will present an overview of the SPORT™ Surgical System as part of his presentation in the Technology Forum at the 13th Meeting of the European Association of Urology (EAU) Robotic Urology Section (ERUS). The meeting is being held in Milan Italy from September 14-16, 2016 and Dr. Sanchez-Salas' presentation will be on Wednesday, September 14, 2016.

The annual ERUS meeting is the scientific platform for urologists seeking the latest technical developments and the continuous progress of urological science and practice. The meeting's aim is to educate the urological community on robotic surgical techniques with the ultimate goal of improving the level of patient care.

ERUS16 will feature high-quality robotic surgery by international experts with interactive moderation. The focus of the meeting will be on practical instructions on robotic surgery with live-surgery sessions and hands-on training courses from the European School of Urology. The highly interactive format of the meeting invites fruitful discussions. A technical exhibition will be held jointly with the meeting, where manufacturers will be showcasing the latest breakthroughs.

The Institute Mutualiste Montsouris (IMM) is a private health institution at the forefront of technological innovations and is among the best establishments in France. IMM has a worldwide reputation for both laparoscopic and robotic procedures and devotes considerable resources in research and technology. The Department of Urology at IMM has been recognized for 15 years as the best in its category on French territory as evidenced by recent publications rankings in the press (No. 1 in urology in the latest charts Figaro Magazine / 2013 and the Point / 2015 best hospitals in France).

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in MIS. The Company's SPORT™ Surgical System, currently under development, includes a surgeon-controlled robotic platform that incorporates a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures through a single incision. The surgical system also includes a surgeon workstation that provides a surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments and provides a 3D high-definition endoscopic view of inside a patient's body. The SPORT™ Surgical System is designed to enable surgeons to perform a broad set of surgical procedures for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website at www.titanmedicalinc.com.

Forward-Looking Statements

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form dated March 30, 2016 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.

Contact Information